发明名称 LYOPHILIZED THERAPEUTIC PEPTIBODY FORMULATION
摘要 PROBLEM TO BE SOLVED: To provide a composition including a protein modified to be capable of blocking mainly exposure of a therapeutic protein to a proteolytic enzyme and protecting the therapeutic protein.SOLUTION: A lyophilized therapeutic peptibody composition includes a buffer, a filler, a stabilizer and optionally a surfactant, where the buffer comprises a pH buffer in the range of about 5 to about 20 mM and has a pH in the range of about 3.0 to about 8.0, the filler has a concentration of about 0 to about 4.5% w/v, the stabilizer has a concentration of about 0.1 to about 20% w/v, the surfactant has a concentration of about 0.004 to about 0.4% w/v, and the therapeutic peptibody includes a structure represented by Formula I: [(X1)a-F1-(X2)b]-(L1)c-WSPd (where, WSP is a water-soluble polymer whose bonding is carried out in any reactive moiety in F1 and F1 is Fc domain).
申请公布号 JP2014040441(A) 申请公布日期 2014.03.06
申请号 JP20130201931 申请日期 2013.09.27
申请人 AMGEN 发明人 CALLAHAN WILLIAM J;RICHARD L REMMELE JR;RATNASWAMY GAYATHRI;RAMIL F LATYPOV;LIU DINGJIANG
分类号 A61K38/00;A61K9/19;A61K47/30;A61K47/34;A61K47/48;A61P3/04;A61P7/00;A61P7/02;A61P9/10;A61P15/00;A61P17/02;A61P17/06;A61P19/02;A61P19/10;A61P25/20;A61P25/28;A61P27/02;A61P29/00;A61P31/12;A61P31/20;A61P35/00;A61P35/04;A61P37/02;A61P37/08;A61P43/00;C07K16/00;C07K19/00;C12N15/09 主分类号 A61K38/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利